Susan G. Komen's ShareForCures
ShareForCures: Susan G. Komen's People-powered, Data-driven Breast Cancer Research Registry
1 other identifier
observational
200,000
1 country
1
Brief Summary
ShareForCures (SFC) is a community-based participatory research registry, and its prime objective is to engage participants representative of the United States breast cancer patient population -including minoritized and historically marginalized people, persons, or communities-to ensure the data researchers use to study breast cancer is as diverse as the people touched by this disease. In doing so, researchers will have a better understanding of breast cancer, and everyone can potentially benefit from scientific advances and improvements in care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 17, 2022
CompletedFirst Submitted
Initial submission to the registry
December 8, 2022
CompletedFirst Posted
Study publicly available on registry
December 16, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2032
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2032
March 6, 2026
March 1, 2026
10 years
December 8, 2022
March 4, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Engage participants representative of the United States breast cancer patient population in ShareForCures.
Enroll and engage up to 200,000 people, who have been diagnosed with breast cancer, reflecting the diversity of breast cancer survivors within the United States, to participate in the registry as our partners in research.
10 years
Integrate participant data into ShareForCures.
Collect and curate a rich scope of participant data from a variety of sources (including participant-provided information, clinical records, and linkage to other existing datasets) and biospecimens to create a comprehensive, longitudinal database.
10 years
Facilitate scientific research using ShareForCures data.
Make deidentified data available to researchers for scientific discoveries, including research that may lead to new knowledge about breast cancer and advances in patient care and outcomes.
10 years
Eligibility Criteria
ShareForCures is open to all individuals diagnosed with breast cancer, age 18 and older, of any gender, and all racial and ethnic origins living in the United States.
You may qualify if:
- Individuals must be at least 18 years old. (Individuals in Alabama and Nebraska must be over 19 and individuals in Mississippi and Pennsylvania must be over 21 to participate).
- Individuals must have been diagnosed with cancer originating (or is suspected to originate) from the breast.
- Individuals must be currently residing in the United States or a territory of the United States.
- Individuals must be able to read and understand English.
You may not qualify if:
- Individuals under the age of 18 years. (Individuals in Alabama and Nebraska under 19 and individuals in Mississippi and Pennsylvania under 21 are not eligible to participate).
- Individuals without a diagnosis of breast cancer.
- Individuals who are not residing in the United States or a territory of the United States.
- Individuals unable to read and understand English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Susan G. Komen
Dallas, Texas, 75380, United States
Biospecimen
ShareForCures plans to leverage different types of biospecimens, including breast cancer tissue (retrospective), blood (retrospective and prospective), and saliva (prospective).
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jerome Jourquin, Ph.D., M.S.
Susan G. Komen
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 8, 2022
First Posted
December 16, 2022
Study Start
November 17, 2022
Primary Completion (Estimated)
November 1, 2032
Study Completion (Estimated)
November 1, 2032
Last Updated
March 6, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Once enough data have been aggregated in ShareForCures, researchers will be able to request access to ShareForCures deidentified data. Data will be available for the duration of the study.
- Access Criteria
- Researchers will be required to formally request access to the data. All requests will be reviewed according to Komen\'s Data Request Review Process. Researchers will also need to execute a Data Transfer and Use Agreement (DTUA), comply with the Researcher Code of Conduct, and abide by other Komen policies and procedures, as needed.
Researchers may request access to SFC data, and upon approval may use the data to answer research questions including studies that will lead to new knowledge about breast cancer and advances in patient care and outcomes. All data sharing will be handled securely and under IRB approval or exemption, following rigorous standards to protect individual privacy and data confidentiality.